Title: Amgen Provides Regulatory Update on Lumakras® Status in Medical Device News Magazine Introduction Amgen, a leading biotechnology company, has...
Dispelling the Myth: A Comprehensive Review of Over 32,000 Cannabis Studies Published in the Last 10 Years Cannabis, also known...
Artificial intelligence (AI) has been making significant strides in various industries, and one area where its potential is truly revolutionary...
Title: Unveiling the Crucial Role of Nkx2-1 in Maintaining Lung Homeostasis and Regeneration Introduction: The lungs are vital organs responsible...
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recently approved three new drugs for use...
FDA Expands Approval for Merck’s $1B Cancer Drug to Treat Wider Range of Patients The U.S. Food and Drug Administration...
The Food and Drug Administration (FDA) has recently expanded the utilization of Merck’s $1 billion cancer drug acquisition, marking a...
Kiromic BioPharma, a clinical-stage biotechnology company, has recently announced the administration of the initial dose to the first participant in...
GSK’s Immuno-Oncology Treatment Receives Groundbreaking Approval in the EU In a groundbreaking development for cancer treatment, GlaxoSmithKline (GSK) has received...
Scientific Reports: Investigating the Powerful Antimicrobial and Anti-Lung Cancer Effects of Bacterial Polysaccharide Coated with Selenium Nanoparticles In recent years,...
Promising Results Found in Lung Cancer Treatment with Antibody-Immunotherapy Combination Lung cancer is one of the most common and deadliest...
Title: FDA Approves Expanded Use of Lilly Cancer Drug for Leukemia and Lymphoma Treatment Introduction In a significant development for...
The Food and Drug Administration (FDA) has recently granted priority review to the combination of Keytruda (pembrolizumab) and Padcev (enfortumab...
Arvinas Secures $350 Million Funding, Exonate’s Trial Achieves Positive Results, and Breakthrough Cancer Drugs Identified In recent news, the biotechnology...
A Promising Treatment Option for Small Cell Lung Cancer Patients Who Have Undergone Prior Treatment: Tarlatamab Small cell lung cancer...
